159 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including … potential of Coherus’ products and product candidates; and the risks and uncertainties of possible litigation. All forward-looking statements contained
8-K
EX-99.1
olixkytfp3ou n4
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.1
tyyh3q5
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-99.1
439x7 6fwvrp
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
8-K
EX-2.1
9ocoabr
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
kqp2b5szr
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
7swdi6qcfi5ke
26 Dec 23
Other Events
8:49pm
8-K
EX-99.1
e3zkn4im6hjgm4w0
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K
EX-99.1
njh93c46id7h9 240tu
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
84ts yqyo1fxc
12 Sep 23
Prospectus supplement for primary offering
6:04am